
29/06/2024
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
Park DJ, Kwon TG, Park JY, Joung JY, Ha HK, Jeon SS, Hong SH, Park S, Lee SH, Cho JS, Park SW, Kwon SY, Jo JK, Park HS, Lee SC, Kwon DD, Kim SI, Park SH, Kim S, Jeong CW, Kwak C, Choi SH, the Korean Urologic Oncology Society Prostate Cancer Group.
World J Mens Health. 2024 Jul;42(3):620-629. English. Original Article. Open Access
Published online January 2, 2024.
Park DJ, et al. World J Mens Health. 2024 Jul;42(3):620-629. https://doi.org/10.5534/wjmh.230104